UNSPSC 85264702: Diagnosis of drug-induced obesity

This classification denotes the group of activities that yields a diagnosis of Drug-induced obesity. Drug-induced obesity is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code E66. 1

UNSPSC 85264702 Diagnosis of drug-induced obesity is a Commodity code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The three most recent opportunities posted under this code are a diagnostic imaging PACS system implementation (San Mateo Medical Center, RFP, due October 21, 2026), special education contracted services across multiple disciplines (Birdville Independent School District, competitive sealed proposal, due October 21, 2026), and a temporary health professional staffing qualification vehicle (Santa Clara County Health System, non-exclusive multiple-award pool, due October 7, 2026). None of these solicitations address drug-induced obesity diagnosis as a clinical service or product line; the code classification appears to be a data-entry or categorization mismatch rather than a reflection of actual procurement need.

The issuing bodies span a county health system, a school district, and a county hospital network across California and Texas, none of which are soliciting obesity-related diagnostics specifically. The geographic spread includes northern California (San Mateo, Santa Clara) and northeast Texas (Tarrant County), but this reflects issuing-body location rather than a coherent procurement signal in the obesity diagnosis category. The code shows no recent relevant activity and does not represent a viable pursuit area for vendors specializing in drug-induced obesity diagnosis services or products.